课题基金 / 基金详情

项目摘要

项目成果

Donald Brambilla的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent NHLBI initiatives to accelerate the progression of scientific discoveries to clinical application include the development of programs to address a lack of resources in specific areas that hinder this progress. An example is the Science Moving towArds Research Translation and Therapy (SMARTT) program, which is designed to provide resources to facilitate the development of therapeutic entities for various diseases of the heart, lung, and blood, and wil include an array of services, including pharmacology/toxicology testing, manufactuing, and a central coordinating function. The coordinating center wil integrate the activities of all the component organizations of the program and provide marketing, regulatory, and inspectional support. RTI International is pleased to submit this proposal to serve as the SMARTT Coordinating Center, providing communication processes that result in productive interactions among all stakeholders; data coordination/information technology solutions to support these communication processes and to coordinate workflow; regulatory affairs/ inspectional support to ensure that program activities are compliant with regulatory guidelines, and a proactive marketing campaign to attract research investigators to the SMARTT program and thereby fully utilize program resources. With over three decades of proven performance on NIH-funded projects requiring integrated data management processes, an information technology team that specializes in all aspects of data collection and monitoring, extensive drg discovery/development and regulatory expertise, and excellent marketing resources, R TI offers all of the skils and resources required for the success of the SMARTT program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)
  • 批准号:
    10166768
  • 项目类别:
  • 资助金额:
    $249.1万
  • 财政年份:
    2020
  • 负责人:
    Donald Brambilla
  • 依托单位:
Clinical Trials Development Resource for Hematologic Disorders (U24)
  • 批准号:
    8353779
  • 项目类别:
  • 资助金额:
    $45.46万
  • 财政年份:
    2012
  • 负责人:
    Donald Brambilla
  • 依托单位:
Clinical Trials Development Resource for Hematologic Disorders (U24)
  • 批准号:
    8693647
  • 项目类别:
  • 资助金额:
    $70.77万
  • 财政年份:
    2012
  • 负责人:
    Donald Brambilla
  • 依托单位:
Clinical Trials Development Resource for Hematologic Disorders (U24)
  • 批准号:
    8882535
  • 项目类别:
  • 资助金额:
    $70.29万
  • 财政年份:
    2012
  • 负责人:
    Donald Brambilla
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: